These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 186603)

  • 21. Bleeding patterns in postmenopausal women using continuous combination hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate or with 17beta-estradiol and norethindrone acetate.
    Odmark IS; Jonsson B; Bäckström T
    Am J Obstet Gynecol; 2001 May; 184(6):1131-8. PubMed ID: 11349178
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The effects of sex steroids on gonadotropins.
    Vorys N; Ullery JC; Stevens V
    Am J Obstet Gynecol; 1965 Nov; 93(5):641-58. PubMed ID: 4284857
    [No Abstract]   [Full Text] [Related]  

  • 23. Menopausal hormone replacement therapy with continuous daily oral micronized estradiol and progesterone.
    Hargrove JT; Maxson WS; Wentz AC; Burnett LS
    Obstet Gynecol; 1989 Apr; 73(4):606-12. PubMed ID: 2538787
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bleeding patterns in postmenopausal women taking continuous combined or sequential regimens of conjugated estrogens with medroxyprogesterone acetate. Menopause Study Group.
    Archer DF; Pickar JH; Bottiglioni F
    Obstet Gynecol; 1994 May; 83(5 Pt 1):686-92. PubMed ID: 8164926
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple therapies for vaginal bleeding secondary to large uterine myomas.
    Thomas MA; Gass ML; Scott MC; Liu JH
    Int J Gynaecol Obstet; 1991 Nov; 36(3):239-41. PubMed ID: 1685460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of two different regimens of continuous hormone replacement therapy on endometrial histopathology and postmenopausal uterine bleeding.
    Yildirim G; Tugrul S; Uslu H; Pekin O; Eren S
    Arch Gynecol Obstet; 2006 Feb; 273(5):268-73. PubMed ID: 16315025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Clinical pharmacology of hormonal contraceptives].
    Hubinont PO; Degueldre M; Delvoye P; L'Hermite M; Robyn C; Vekemans M
    Bull Mem Acad R Med Belg; 1975; 130(7-9):351-67. PubMed ID: 800347
    [No Abstract]   [Full Text] [Related]  

  • 28. Pharmacophysiologic and clinical aspects of oral contraceptives.
    Balin H; Newton RE; Hontz AC; LoSciuto LA
    Semin Drug Treat; 1973; 3(2):121-42. PubMed ID: 4131558
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical and cytologic responses of postmenopausal women to estrogen.
    Lin TJ; So-Bosita JL; Brar HK; Roblete BV
    Obstet Gynecol; 1973 Jan; 41(1):97-107. PubMed ID: 4345382
    [No Abstract]   [Full Text] [Related]  

  • 30. Two new combinations of estrogen and progestogen for prevention of postmenopausal bone loss: long-term effects on bone, calcium and lipid metabolism, climacteric symptoms, and bleeding.
    Marslew U; Overgaard K; Riis BJ; Christiansen C
    Obstet Gynecol; 1992 Feb; 79(2):202-10. PubMed ID: 1309944
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Endometrial histology and bleeding patterns after 8 years of continuous combined estrogen and progestogen therapy in postmenopausal women.
    Leather AT; Savvas M; Studd JW
    Obstet Gynecol; 1991 Dec; 78(6):1008-10. PubMed ID: 1658699
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Does hormone replacement therapy affect disease activity in patients with systemic lupus erythematosus?
    Ramsey-Goldman R
    Nat Clin Pract Rheumatol; 2005 Dec; 1(2):72-3. PubMed ID: 16932632
    [No Abstract]   [Full Text] [Related]  

  • 33. Endothelin plasma levels in primary amenorrheic adolescents before and after estrogen treatment.
    Creatsas GC; Malamitsi-Puchner AB; Hassan EA; Economou EB; Aravantinos DI
    J Soc Gynecol Investig; 1996; 3(6):350-3. PubMed ID: 8923420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Endometrial carcinoma and oral contraceptive agents.
    Cohen CJ; Deppe G
    Obstet Gynecol; 1977 Apr; 49(4):390-2. PubMed ID: 193073
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Is hormone replacement therapy for me?
    Miller AD
    JAAPA; 2009 Jul; 22(7):57. PubMed ID: 19697573
    [No Abstract]   [Full Text] [Related]  

  • 36. Postmenopausal uterine bleeding due to estrogen production by gonadotropin-secreting lung tumors.
    Smith LG; Lyubsky SL; Carlson HE
    Am J Med; 1992 Mar; 92(3):327-30. PubMed ID: 1312306
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Endocrinologic aspects of dysfunctional uterine bleeding.
    Sobrinho LG; Kase N
    Clin Obstet Gynecol; 1970 Jun; 13(2):400-15. PubMed ID: 4993047
    [No Abstract]   [Full Text] [Related]  

  • 38. Endocrine approach in the management of dysfunctional uterine bleeding.
    Garcia CR
    Clin Obstet Gynecol; 1970 Jun; 13(2):460-73. PubMed ID: 4322145
    [No Abstract]   [Full Text] [Related]  

  • 39. Evaluation of mastodynia in postmenopausal women taking hormone therapy.
    Carranza-Lira S; Garduño-Hernández MP; Caisapanta DA; Aparicio H
    Int J Gynaecol Obstet; 2005 May; 89(2):158-9. PubMed ID: 15847887
    [No Abstract]   [Full Text] [Related]  

  • 40. [Change in the content of follicle-stimulating and luteinizing hormones and estrogens in the urine during progesterone treatment of dysfunctional uterine hemorrhages].
    Savchenko ON; Sokolov EG; Khrustaleva GF
    Akush Ginekol (Mosk); 1972 Apr; 48(4):46-50. PubMed ID: 4639206
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.